Antimicrobial Resistance Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Antimicrobial Resistance. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Antimicrobial Resistance Indian Medical PG Question 1: What is the best way to control the MRSA infection in the ward?
- A. Fumigation of ward frequently
- B. Washing hand before and after attending patients (Correct Answer)
- C. Wearing masks during invasive procedures in ICU
- D. Vancomycin given empirically to all the patients
Antimicrobial Resistance Explanation: **Washing hand before and after attending patients**
- **Hand hygiene** is the single most effective measure in preventing the transmission of **healthcare-associated infections**, including **MRSA**.
- **Healthcare workers' hands** are the primary vehicle for spreading pathogens from one patient to another.
*Fumigation of ward frequently*
- **Fumigation** is generally not recommended for routine infection control and has limited efficacy against resistant organisms like **MRSA** in this context.
- It does not address the primary mode of transmission, which is direct contact via **contaminated hands** or surfaces.
*Wearing masks during invasive procedures in ICU is important.*
- While important for preventing infections during **invasive procedures** and protecting against **aerosolized pathogens**, masks are not the primary strategy for controlling the spread of **MRSA** in routine ward settings.
- **MRSA transmission** is predominantly contact-based, not airborne.
*Vancomycin given empirically to all the patients*
- **Empirical broad-spectrum antibiotic use** for all patients is a significant driver of **antibiotic resistance**, including **MRSA**.
- It should be reserved for patients with suspected or confirmed **MRSA infections** based on clinical criteria and culture results, not as a general preventive measure.
Antimicrobial Resistance Indian Medical PG Question 2: Antibiotic sensitivity and resistance of microorganisms are determined by
- A. DNA probe
- B. Direct microscopy
- C. ELISA
- D. Culture (Correct Answer)
Antimicrobial Resistance Explanation: ***Culture***
- **Culture** allows for the isolation and growth of microorganisms, which is essential for subsequent testing of their susceptibility to various antibiotics.
- Standardized methods like the **Kirby-Bauer disk diffusion method** or **broth microdilution** are performed on cultured organisms to determine antibiotic sensitivity and resistance.
*DNA probe*
- **DNA probes** are primarily used for identifying specific genes or sequences within a microorganism, often for rapid identification or detection of resistance genes, but not for direct determination of phenotypic susceptibility.
- While they can detect genetic markers associated with resistance, they don't directly measure how an antibiotic affects the *growth* of the organism.
*Direct microscopy*
- **Direct microscopy** is used to visualize microorganisms, determine their morphology, and estimate their quantity in a sample.
- It does not provide information about a microorganism's ability to grow in the presence of antibiotics.
*ELISA*
- **ELISA (Enzyme-Linked Immunosorbent Assay)** is an immunological test used to detect antigens or antibodies in a sample.
- It is used for diagnosis of infections or detection of toxins, but not for determining the susceptibility of microorganisms to antibiotics.
Antimicrobial Resistance Indian Medical PG Question 3: All of the following are true about methicillin resistance in MRSA, except:
- A. Resistance is produced as a result of altered PBPs
- B. Resistance may be missed at incubation temperature of 37°C during susceptibility testing
- C. Resistance is primarily mediated/transmitted by plasmids (Correct Answer)
- D. Resistance is associated with increased minimum inhibitory concentrations (MICs) for beta-lactam antibiotics
Antimicrobial Resistance Explanation: ***Resistance is primarily mediated/transmitted by plasmids***
- Methicillin resistance in MRSA is primarily mediated by the acquisition of the **mecA gene**, which encodes for an altered **penicillin-binding protein (PBP2a)**.
- The mecA gene is located on a **staphylococcal chromosomal cassette mec (SCCmec)**, a mobile genetic element integrated into the bacterial chromosome, and **not transmitted via plasmids**.
- This is the **false statement** and hence the correct answer to this "except" question.
*Resistance is produced as a result of altered PBPs*
- This statement is **true** as MRSA acquires the **mecA gene**, which encodes for an altered penicillin-binding protein, **PBP2a**.
- **PBP2a** has a low affinity for beta-lactam antibiotics, allowing the bacterium to synthesize its cell wall even in the presence of these drugs.
*Resistance may be missed at incubation temperature of 37°C during susceptibility testing*
- This statement is **true**; **MRSA expression** can be heterogeneous and temperature-dependent.
- Optimal detection of methicillin resistance often requires incubation at **lower temperatures (e.g., 30-35°C)** and/or the addition of salt (2-4% NaCl), as 37°C can sometimes mask the heterogeneous expression of resistance.
*Resistance is associated with increased minimum inhibitory concentrations (MICs) for beta-lactam antibiotics*
- This statement is **true**; the presence of **PBP2a** results in reduced binding of beta-lactam antibiotics to their target.
- This leads to **increased MICs** for methicillin and other beta-lactam antibiotics, defining the resistance phenotype.
Antimicrobial Resistance Indian Medical PG Question 4: Extended-spectrum beta-lactamases (ESBLs) are characterized by activity against all except :
- A. Carbapenems (Correct Answer)
- B. Oxyimino-cephalosporins
- C. Penicillins
- D. Cephalosporins
Antimicrobial Resistance Explanation: ***Carbapenems***
- **Extended-spectrum beta-lactamases (ESBLs)** typically do not hydrolyze **carbapenems**, making these antibiotics generally effective against most ESBL-producing bacteria.
- The retention of activity against carbapenems is a key distinction between ESBLs and other beta-lactamases like **carbapenemases**.
*Oxyimino-cephalosporins*
- ESBLs are specifically named for their ability to hydrolyze and inactivate **oxyimino-cephalosporins**, such as **cefotaxime**, **ceftriaxone**, and **ceftazidime**.
- This hydrolysis makes these vital third-generation cephalosporins ineffective for treating infections caused by ESBL-producing organisms.
*Penicillins*
- ESBLs can effectively hydrolyze and render many **penicillins** inactive, especially those lacking beta-lactamase inhibitors.
- This broadens the resistance spectrum beyond just cephalosporins to include common penicillins.
*Cephalosporins*
- ESBLs primarily confer resistance to a wide range of **cephalosporins**, particularly the **first-, second-, and third-generation agents**.
- This resistance is a major clinical challenge, necessitating the use of alternative antibiotic classes.
Antimicrobial Resistance Indian Medical PG Question 5: Production of inactivating enzymes is an important mechanism of drug resistance for all of these antibiotics EXCEPT
- A. Quinolone (Correct Answer)
- B. Penicillin
- C. Chloramphenicol
- D. Aminoglycoside
Antimicrobial Resistance Explanation: ***Quinolone***
- The primary mechanisms of resistance to **quinolones** involve mutations in the **gyrase** and **topoisomerase IV** enzymes or efflux pump overexpression, rather than enzymatic inactivation of the drug itself.
- Unlike other antibiotic classes listed, quinolones are not typically susceptible to bacterial enzymes that degrade or modify their structure.
*Penicillin*
- **Penicillins** are highly susceptible to inactivation by **beta-lactamase enzymes**, which hydrolyze the beta-lactam ring, rendering the antibiotic ineffective.
- This enzymatic degradation is a major mechanism of resistance developed by many bacterial species to penicillin and other beta-lactam antibiotics.
*Chloramphenicol*
- Resistance to **chloramphenicol** is primarily mediated by the enzyme **chloramphenicol acetyltransferase (CAT)**, which acetylates the drug, preventing its binding to the bacterial ribosome.
- This enzymatic modification is a classic example of drug inactivation leading to resistance.
*Aminoglycoside*
- **Aminoglycosides** are frequently inactivated by a variety of **aminoglycoside-modifying enzymes (AMEs)**, such as acetyltransferases, phosphoryltransferases, and nucleotidyltransferases.
- These enzymes add chemical moieties to the aminoglycoside molecule, preventing its binding to the bacterial ribosome and inhibiting protein synthesis.
Antimicrobial Resistance Indian Medical PG Question 6: Multiple drug resistance is transferred through -
- A. Transduction
- B. Transformation
- C. Conjugation (Correct Answer)
- D. Mutation
Antimicrobial Resistance Explanation: ***Conjugation***
- Conjugation is a primary mechanism for the spread of **antibiotic resistance genes** among bacteria, including those responsible for multiple drug resistance.
- It involves the direct transfer of **plasmids** (which often carry resistance genes) from one bacterial cell to another through a pilus.
*Transduction*
- Transduction is the process where bacteria acquire foreign DNA, including resistance genes, via a **bacteriophage (virus)**.
- While it can transfer resistance, conjugation is a more common and clinically significant route for **multidrug resistance** spread.
*Transformation*
- Transformation involves the uptake of **naked DNA** from the environment by a bacterial cell.
- While bacteria can acquire resistance genes this way, it is less efficient for widespread, rapid transfer of **multiple resistance traits** compared to conjugation.
*Mutation*
- Mutation refers to a change in the bacterial organism's own DNA, which can lead to the development of **drug resistance**.
- However, mutation explains the *origin* of resistance in a single bacterium, not the *transfer* of resistance genes (especially multiple resistance) between different bacteria.
Antimicrobial Resistance Indian Medical PG Question 7: One of your staff nurses sustained a deep needle stick injury from a needle used to inject an HIV positive individual. What is the treatment regime that should be started in her/him? Note that drug resistance was suspected in the HIV patient.
- A. 2 NIs for 3 months
- B. 2 NIs + 1 protease inhibitor for 28 days (Correct Answer)
- C. 2 protease inhibitors + 2 NtIs for 3 months
- D. 1 NI and 1 NtI for 28 days
Antimicrobial Resistance Explanation: ***2 NIs + 1 protease inhibitor for 28 days***
- For **occupational post-exposure prophylaxis (PEP)** involving a significant exposure to HIV with suspected drug resistance in the source patient, a **three-drug regimen** is recommended [2].
- This typically includes **two nucleoside reverse transcriptase inhibitors (NRTIs)** and **one protease inhibitor (PI)**, administered for **28 days**. This combination provides potent antiviral activity and addresses potential resistance [2].
*2 NIs for 3 months*
- A **two-drug regimen** of NRTIs alone is generally considered **insufficient** for PEP, especially when drug resistance in the source is suspected [2].
- While PEP is typically given for 28 days, a 3-month duration is longer than standard and not justified by a two-drug regimen [1].
*2 protease inhibitors + 2 NtIs for 3 months*
- This regimen involves **too many drugs** (four) and an **excessively long duration** (3 months) for standard occupational PEP.
- While it offers strong antiviral coverage, the increased risk of **side effects** and **patient non-adherence** outweighs the benefits unless specific, rare circumstances dictate such an aggressive approach [2].
*1 NI and 1 NtI for 28 days*
- This regimen contains an **insufficient number of drugs** (only two, one NI and one NtI, which is essentially two NRTIs if 'NtI' refers to nucleotide analogue reverse transcriptase inhibitor) and may not be powerful enough to prevent HIV transmission, especially with suspected drug resistance [2].
- A **three-drug regimen** is the standard for high-risk exposures.
Antimicrobial Resistance Indian Medical PG Question 8: Two students from a university dormitory building have contracted meningitis due to Neisseria meningitides. Which of the following students in the dormitory are most likely to benefit from chemoprophylaxis?
- A. close contacts only, with oral rifampin (Correct Answer)
- B. everybody in the dormitory, with oral rifampin
- C. close contacts only, with oral amoxicillin
- D. everybody in the dormitory, with oral amoxicillin
Antimicrobial Resistance Explanation: ***close contacts only, with oral rifampin***
- **Chemoprophylaxis** for *Neisseria meningitidis* is primarily recommended for **close contacts** due to the direct person-to-person transmission mode [1].
- **Oral rifampin** is an effective antibiotic for prophylaxis as it penetrates pharyngeal secretions and eliminates carriage of the bacteria [1].
*everybody in the dormitory, with oral rifampin*
- Administering chemoprophylaxis to **everyone** in the dormitory is **excessive** and not indicated, as the risk of transmission is highest among close contacts [1].
- Widespread indiscriminate use of antibiotics like rifampin can contribute to **antibiotic resistance**.
*close contacts only, with oral amoxicillin*
- While prophylaxis is correctly targeted at **close contacts**, **amoxicillin** is generally **not recommended** for *N. meningitidis* chemoprophylaxis.
- Amoxicillin does not reliably eradicate meningococcal carriage from the nasopharynx and is therefore **ineffective** for prophylaxis.
*everybody in the dormitory, with oral amoxicillin*
- This option is incorrect because both the scope of administration (**everybody in the dormitory**) and the choice of antibiotic (**amoxicillin**) are inappropriate.
- **Amoxicillin** is not effective for clearing *N. meningitidis* carriage, and widespread use is not justified for prophylaxis.
Antimicrobial Resistance Indian Medical PG Question 9: A 22-year-old man presents with urethral discharge and dysuria for 3 days. Gram stain shows intracellular gram-negative diplococci. Two weeks after appropriate treatment, he returns with similar symptoms. Repeat testing shows no organisms on Gram stain but leukocytes are present. What is the most likely explanation?
- A. Antibiotic resistance
- B. Reinfection with N. gonorrhoeae
- C. Concurrent chlamydial infection (Correct Answer)
- D. Urethral stricture
Antimicrobial Resistance Explanation: ***Concurrent chlamydial infection***
- The initial presentation was consistent with **gonorrhea** (intracellular gram-negative diplococci). After initial treatment, the recurrence of symptoms with **leukocytes but no organisms on Gram stain** is highly suggestive of a co-existing infection that would not be visible on Gram stain or sensitive to the initial gonorrhea treatment [1].
- **Chlamydial infections** are frequently co-transmitted with gonorrhea and present with similar symptoms, often causing **post-gonococcal urethritis** when the gonorrhea is treated but the chlamydia is not [3].
*Antibiotic resistance*
- If it were antibiotic resistance, the **intracellular gram-negative diplococci** would likely still be present on repeat Gram stain after treatment, rather than absent.
- While possible, the absence of organisms on repeat Gram stain makes this less likely than a co-infection with a pathogen not detectable by Gram stain.
*Reinfection with N. gonorrhoeae*
- Reinfection would imply a new exposure and would again show **intracellular gram-negative diplococci** on Gram stain, which are explicitly stated to be absent.
- Although possible, the rapid recurrence (2 weeks) and absence of the original organism make another pathogen more probable.
*Urethral stricture*
- A urethral stricture could cause persistent or recurrent symptoms like dysuria and discharge, but it would not typically be associated with the acute presence of **leukocytes** in the absence of an active infection.
- Strictures are mechanical issues and would not explain the initial finding of gram-negative diplococci or the subsequent sterile pyuria [2].
Antimicrobial Resistance Indian Medical PG Question 10: A patient with gonorrhea infection shows persistence of symptoms despite appropriate treatment with Ceftriaxone. Which of the following best explains this treatment failure?
- A. Reinfection from untreated partner (Correct Answer)
- B. Host immune deficiency
- C. Initial misdiagnosis
- D. Development of new resistance during therapy
Antimicrobial Resistance Explanation: ***Reinfection from untreated partner***
- The most common reason for persistent gonorrhea symptoms despite appropriate treatment is **re-exposure** to the infection from an **untreated sexual partner** [1].
- This highlights the importance of **partner notification and treatment** in managing sexually transmitted infections [1].
*Host immune deficiency*
- While host immune status can influence the severity or recurrence of infections, a primary **immune deficiency** is a less common explanation for treatment failure of uncomplicated gonorrhea, especially with an effective antibiotic like ceftriaxone.
- Gonorrhea is typically managed effectively with standard antibiotic regimens, even in individuals with common viral infections like HIV, unless there are severe, unmanaged coinfections or systemic immunosuppression.
*Initial misdiagnosis*
- An initial misdiagnosis could lead to persistent symptoms if the patient never had gonorrhea or had another co-infection that was not treated. However, the question states "gonorrhea infection" and "appropriate treatment with Ceftriaxone," implying the diagnosis was correct and the treatment regimen was standard.
- This option does not explain why the **specific treatment for gonorrhea** failed, but rather suggests a fundamental error in the diagnostic process.
*Development of new resistance during therapy*
- Although **antibiotic resistance** in *Neisseria gonorrhoeae* is a growing concern, the development of *new* resistance mutations *during* a typical short course of effective ceftriaxone treatment for an initial infection is rare [1].
- More commonly, resistance profiles are established before treatment, or an existing resistant strain was acquired, rather than a new mutation arising and causing failure within the short therapeutic window.
More Antimicrobial Resistance Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
